Pricing Log in Create free account

Addex Therapeutics Ltd. Sponsored ADR (ADXN) vs KALA BIO, Inc. (KALA)

Addex Therapeutics Ltd. Sponsored ADR and KALA BIO, Inc. are both Biotechnology companies. Addex Therapeutics Ltd. Sponsored ADR and KALA BIO, Inc. are of similar size ($3.1M and $3.0M). KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −75.8%. Across the 13 metrics below, KALA BIO, Inc. leads on 8 and Addex Therapeutics Ltd. Sponsored ADR on 5.

Valuation

Metric ADXN KALA Biotechnology median
P/E n/m n/m 10.60
P/S 12.90 0.52 9.40
P/B 1.23 0.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 8.67 8.04 9.02
Earnings yield (302.94%) (31,890.31%) (32.88%)
Free cash flow yield (99.60%) (667.16%) (23.13%)

Profitability

Metric ADXN KALA Biotechnology median
Gross margin 43.88% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.91%) (345.32%) (51.96%)
Return on assets (117.46%) (43.23%) (46.06%)
Return on invested capital (141.24%) (722.69%) 0.00%

Growth

Metric ADXN KALA Biotechnology median
Revenue growth (TTM) (75.77%) (50.54%) 6.76%
EPS growth (last fiscal year) (191.09%) 67.39% 29.88%
Revenue growth, 5-year CAGR (60.68%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADXN KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 6.88 4.97
Net debt to EBITDA 0.58 0.19 1.01

Dividend

Metric ADXN KALA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADXN KALA Biotechnology median
Market cap 3.07m 2.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack